Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kelsey Guth

Optometrist, Pediatrics Williamsburg, VA Doctor of Optometry

NPI 1992188114 CMS profile 1370295

5215 Monticello Ave Ste A, Williamsburg, VA 23188

Open in the dashboard

General payments

$8,067

86 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$11,365 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Kelsey Guth of Williamsburg, VA is reported in the CMS Open Payments database as having received $8,067 across 86 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $11,365 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Optometrist, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,300 17
2024 General $750 14
2023 General $1,691 24
2022 General $209 3
2021 General $54 3
2020 General $17 1
2019 General $2,046 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kelsey Guth
  • Optometrist, Pediatrics median
  • Middle half of Optometrist, Pediatrics
  • National median

In program year 2025, general payments to Kelsey Guth were reported at $3,300. Among 126 Optometrist, Pediatrics profiles paid that year, the median was $152 and the middle half received between $55 and $398.

Show as a table
Year Kelsey Guth Optometrist, Pediatrics median Middle half National median
2019 $2,046 $119 $40–$274 $163
2020 $17 $62 $19–$143 $114
2021 $54 $126 $50–$266 $132
2022 $209 $116 $38–$270 $149
2023 $1,691 $188 $64–$450 $160
2024 $750 $125 $48–$342 $164
2025 $3,300 $152 $55–$398 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CooperVision Inc. $3,586 17 payments
  2. Alcon Vision LLC $2,884 46 payments
  3. Bausch & Lomb, a division of Bausch Health US, LLC $214 2 payments
  4. Sun Pharmaceutical Industries Inc. $195 4 payments
  5. Tarsus Pharmaceuticals, Inc. $185 3 payments
  6. Alimera Sciences, Inc. $164 1 payment
  7. Johnson & Johnson Vision Care, Inc. $149 3 payments
  8. Bausch & Lomb Americas Inc. $140 2 payments
  9. LKC Technologies, Inc. $127 1 payment
  10. Allergan Inc. $125 1 payment
  11. Other $298 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,903 74 payments
  2. Travel and Lodging $2,611 8 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 1 payment
  4. Entertainment $35 2 payments
  5. Gift $17 1 payment
Products named General payments · program years 2019–2025
  1. MiSight Contact Lens $3,538 13 payments
  2. DAILIES $1,066 11 payments
  3. TOTAL30 $653 15 payments
  4. AIR OPTIX $530 3 payments
  5. Precision7 $332 5 payments
  6. DAILIES TOTAL1 $312 4 payments
  7. Precision 1 $233 3 payments
  8. ULTRA $214 2 payments
  9. Cequa $195 4 payments
  10. XDEMVY $185 3 payments
  11. Other $2,360 41 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 9 billing codes

Paid by Medicare

$2,396

Medicare's payments for the services billed

Medicare patients

35

Average age 74

Services billed

215

24 women, 11 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 54%
Arthritis 46%
Cancer 31%
Osteoporosis 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XDEMVY
  • Tarsus Pharmaceuticals, Inc. $124
$124 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist, Pediatrics in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record